Fund moves

Johnson & Johnson (JNJ): Glenview Trust Co reduced its stake -2,720 shares

Glenview Trust Co reduced its stake in Johnson & Johnson, per its Q1 2025 13F.

151K
Shares reported · -2,720 vs prior quarter
0.49%
Disclosed portfolio weight
$25M
Reported value
Holdings as of
Mar 31, 2025
Filed
May 20, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 15, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  2. Aug 7, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  3. Sep 26, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  4. Oct 29, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  5. Mar 3, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  6. Mar 4, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  7. Mar 5, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  8. Mar 7, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  9. Mar 24, 2025CongressDisclosed sale of JNJ — reported range $100,001 - $250,000
  10. Mar 31, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  11. Apr 1, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  12. Apr 8, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  13. Apr 9, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  14. Apr 21, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  15. Apr 29, 2025FDAFDA drug approval: Imaavy
  16. Apr 29, 2025Congress · 1 personMembers of Congress: 2 sales
  17. May 2, 2025FDAFDA device clearance: Shockwave CS Guide Catheter
  18. May 5, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  19. May 12, 2025CongressDisclosed sale of JNJ — reported range $50,001 - $100,000
  20. May 14, 2025FDAFDA device clearance: ETHICON 4000 60mm Compact Stapler (EC3D60C); ETHICON 4000 60mm Standard Stapler (EC3D60S); ETHICON 4000 60mm Long Stapler (EC3D60L); ETHICON 3D 60mm White Relo…

What came next

  1. May 23, 2025FDAFDA device clearance: RECLAIM Monobloc Revision Femoral Stem
  2. May 30, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  3. Jun 10, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  4. Jun 12, 2025FDARecall: ACUVUE¿ OASYS MAX 1-Day MULTIFOCAL
  5. Jun 12, 2025CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
  6. Jun 16, 2025CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
  7. Jun 17, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  8. Jun 23, 2025FDARecall: Automated Impella Controller (AIC), used in left heart support blood pump, including the following: 1. Impella Controller, Packaged, AU; Product Code: 0042-000…
  9. Jun 24, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  10. Jul 17, 2025InsiderOfficer sold ~$3.13M of JNJ shares in the open market
  11. Jul 28, 2025FDAFDA drug approval: Sirturo
  12. Jul 31, 2025CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
  13. Aug 4, 2025Congress · 1 personMembers of Congress: 2 purchases
  14. Aug 14, 2025FDAFDA drug approval: Rybrevant
  15. Aug 14, 2025FDAFDA drug approval: Lazcluze
  16. Aug 14, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  17. Aug 15, 2025FDARecall: STRATAFIX Spiral PDS Plus Bidirectional Knotless Tissue Control Device, SFX SPI PDS+ BI VIO 14X14IN(36X36CM) USP1(M4) D/A MO-4. Product Code: SXPP2B400-11.
  18. Aug 15, 2025InsiderCFO sold ~$2.98M of JNJ shares in the open market
  19. Aug 19, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  20. Aug 20, 2025FDARecall: Automated Impella Controller (AIC) with the below brands and product codes. Used with heart assist pump. 1. Impella Controller, Packaged, US; Product Code: 004…
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 4 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

How this filing works

Explore the data

Common questions

What does this filing report about Johnson & Johnson (JNJ) stock?

Glenview Trust Co reduced its stake in Johnson & Johnson, per its Q1 2025 13F. Now 151K shares, $25M reported value, 0.49% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Mar 31, 2025. Filed: May 20, 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Johnson & Johnson recently?

For Johnson & Johnson, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 4 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days. They are listed on the JNJ page.

Does this mean JNJ stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data